We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App





Swab-Based Rapid Test Uses UV Spectrometer to Detect All COVID-19 Variants

By LabMedica International staff writers
Posted on 08 Apr 2022

A new swab-based rapid test uses a UV spectrometer for detection of the spike protein of SARS-CoV-2 and will cover all COVID-19 variants, as well as any future variants. More...

In August 2020, a nanotechnology research group at the University of Georgia (Athens, GA, USA) had tested nanotechnology-based optical sensors designed for COVID-19 detection and saw the potential for their home-grown technology. The group has now filed a patent application and published its first paper on rapid detection of COVID-19, using a localized surface plasmon resonance (LSPR) virus sensor, developed based on human angiotensin-converting enzyme 2 protein (ACE2) functionalized silver nanotriangle arrays. The sensor has high sensitivity and specificity to the spike protein RBD of SARS-CoV-2 as well as human coronavirus NL63. The team is now developing a detector based on this work within USD 10 and the sensor will link to a smartphone app.

“Right now, we already have rapid antigen test kits available on the market, though the big issue continues to be the high rate of false positives, around 60%,” said Yanjun Yang, doctoral student in the UGA College of Engineering and lead author on the new paper. “Our technology, also in a rapid kit but using a spectrometer to do the detection, is much more accurate.”

“The method we developed shall have a much better sensing performance than the rapid test kits, very close to the PCR tests currently in use,” said Yiping Zhao, Distinguished Research Professor in the Franklin College of Arts and Sciences department of physics and astronomy. “The setup and the operation of the sensor is very simple, and the test time essentially will be less than 10 minutes.”

“The LSPR sensor has several advantages in rapid diagnostics of SARS-CoV-2 (CoV2). Highly sensitive, specific, and able to detect CoV2 at picomolar concentrations in saliva, it’s rapidity at less than 20 minutes is as good or better than current diagnostic platforms including RT-qPCR, also known as the ‘gold standard’,” said Ralph Tripp, professor and GRA Chair in Vaccine and Therapeutic Development in the College of Veterinary Medicine department of infectious diseases and co-author on the study. “In addition, this method of detection is highly reproducible. This platform is a significant leap forward in diagnostics.”

Related Links:
University of Georgia 


Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
Online QC Software
Acusera 24•7
Immunofluorescence Analyzer
IFA System
HPV Molecular Test
BD Onclarity HPV Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A new study identifies distinct metabolomic signatures in maternal blood associated with both the timing and type of early birth (Image credit: iStock)

Maternal Blood Biomarkers Identify Risk of Preterm and Early-Term Birth

Preterm and early-term births can lead to lasting complications because vital organs continue to mature during the final weeks of pregnancy. Babies born too soon face increased risks of breathing difficulties,... Read more

Molecular Diagnostics

view channel
Image: The LIAISON NES point-of-care molecular diagnostics platform expands its menu with a rapid molecular assay for Group A Streptococcus (Photo courtesy of Diasorin)

Point-of-Care Molecular Test Detects Group A Strep in Minutes

Group A Streptococcus is a leading bacterial cause of acute pharyngitis and a common reason for outpatient visits, accounting for millions of healthcare encounters each year. Because symptoms of bacterial... Read more

Microbiology

view channel
Image: Burkholderia pseudomallei is a soil-dwelling bacterium that causes melioidosis, a severe and potentially fatal infection that remains difficult to diagnose (Image Credit: Gavin Koh/Wikimedia Commons, CC BY-SA 4.0)

Stronger Laboratory Services Support Timely Melioidosis Diagnosis Amid Global Spread

Melioidosis, a potentially fatal infection caused by Burkholderia pseudomallei, remains difficult to recognize because its symptoms can mimic tuberculosis and other illnesses. The disease is considered... Read more

Industry

view channel
Image

QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools

QIAGEN (Venlo, Netherlands) has introduced additions to its QIAcuity dPCR ecosystem that focus on gene expression, expanded assay content, and workflow standardization for life sciences and biopharma users.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.